MCID: GST009
MIFTS: 51

Gastroschisis malady

Categories: Rare diseases, Gastrointestinal diseases, Fetal diseases

Aliases & Classifications for Gastroschisis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 27ICD10, 29ICD9CM, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet
See all MalaCards sources

Aliases & Descriptions for Gastroschisis:

Name: Gastroschisis 10 45 47 12 51 36 65
Congenital Fissure of the Abdominal Cavity 45
 
Laparoschisis 51

Characteristics:

Orphanet epidemiological data:

51
gastroschisis:
Inheritance: Not applicable; Prevalence: 1-5/10000 (Europe),1-5/10000 (Austria),1-5/10000 (Belgium),1-5/10000 (Croatia),1-5/10000 (Denmark),1-5/10000 (France),1-5/10000 (Germany),1-9/100000 (Hungary),1-5/10000 (Ireland),1-9/100000 (Italy),1-5/10000 (Malta),1-5/10000 (Netherlands),1-5/10000 (Norway),1-5/10000 (Poland),1-5/10000 (Portugal),1-9/100000 (Spain),1-5/10000 (Switzerland),1-5/10000 (United Kingdom),1-9/100000 (Ukraine); Age of onset: Antenatal,Neonatal; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology10 DOID:11044
ICD1027 Q79.3
ICD9CM29 756.73
MeSH36 D020139
NCIt42 C84725
SNOMED-CT59 72951007
Orphanet51 2368
UMLS via Orphanet66 C0265706
ICD10 via Orphanet28 Q79.3
MESH via Orphanet37 D020139
UMLS65 C0265706

Summaries for Gastroschisis

About this section
Wikipedia:68 Gastroschisis represents a congenital defect characterised by a defect in the anterior abdominal wall... more...

MalaCards based summary: Gastroschisis, also known as congenital fissure of the abdominal cavity, is related to abdominal wall defect and omphalocele, and has symptoms including gastroschisis, intestinal atresia/stenosis/absence/agenesis/hypoplasia (excludes duodenum) and mesenterium anomaly/common mesentery/mesenteric adhesion. An important gene associated with Gastroschisis is BMP1 (Bone Morphogenetic Protein 1), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and Immune response_MIF-mediated glucocorticoid regulation. Affiliated tissues include skin, liver and breast, and related mouse phenotypes are muscle and hematopoietic system.

Related Diseases for Gastroschisis

About this section

Diseases related to Gastroschisis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 101)
idRelated DiseaseScoreTop Affiliating Genes
1abdominal wall defect10.8
2omphalocele10.7
3laparoschisis10.4
4crohn's disease10.4F5, IL6
5sugarman brachydactyly10.4F5, IL6
6oral mucosa leukoplakia10.4IL6, NPPA
7maple bark strippers' lung10.4F5, IL6
8eccrine sweat gland neoplasm10.3F5, IL6
9focal embolic glomerulonephritis10.3IL6, MPO
10protein s deficiency10.3F5, IL6
11partial circumpapillary choroid dystrophy10.3IL6, MPO
12idiopathic hypersomnia10.3MPO, NPPA
13intestinal atresia10.2
14papillary pattern testicular yolk sac tumor10.2F5, MPO
15cutaneous paget's disease10.2F5, IL6
16oral squamous cell carcinoma10.2F5, MPO
17acute zonal occult outer retinopathy10.2F5, IL6
18signet ring cell variant cervical mucinous adenocarcinoma10.2NPPA, TGFB3
19focal labyrinthitis10.2F5, MPO
20retinitis pigmentosa10.2F5, IL6
21villoglandular variant cervical mucinous adenocarcinoma10.2IL6, MPO
22adult spinal cord glioblastoma multiforme10.1F5, IL6
23fetal erythroblastosis10.1F5, MPO
24childhood kidney angiomyolipoma10.1IL6, MPO
25childhood kidney cell carcinoma10.1ICAM1, IL6
26monckeberg arteriosclerosis10.1ICAM1, IL6
27spinal canal and spinal cord meningioma10.1IL6, NPPA, TGFB3
28parasitic helminthiasis infectious disease10.0ICAM1, TGFB3
29dancing eyes-dancing feet syndrome10.0ICAM1, IL6
30congenital diaphragmatic hernia10.0
31dyskinesia of esophagus10.0ICAM1, IL6
32hypopharynx cancer10.0ICAM1, IL6
33pyrimidine metabolic disorder10.0ICAM1, IL6
34keratomalacia10.0ICAM1, IL6
35exudative glomerulonephritis9.9ICAM1, MPO
36angioedema9.9ICAM1, MPO
37crescentic glomerulonephritis9.9ICAM1, MPO
38conduct disorder9.9ICAM1, MPO
39paraomphalocele9.9
40qualitative platelet defect9.9ICAM1, MPO
41short bowel syndrome9.9
42esophagitis9.9
43oligohydramnios9.9
44chylous ascites9.9
45liver leiomyosarcoma9.9F5, IL6, MPO
46timothy grass allergy9.9ICAM1, MPO
47tuberculoid leprosy9.8ICAM1, MPO
48suppurative uveitis9.8ICAM1, MPO
49conjunctivochalasis9.8ICAM1, IL6
50neural tube defects9.8

Graphical network of the top 20 diseases related to Gastroschisis:



Diseases related to gastroschisis

Symptoms for Gastroschisis

About this section

Symptoms:

 51
  • gastroschisis
  • intestinal atresia/stenosis/absence/agenesis/hypoplasia (excludes duodenum)
  • mesenterium anomaly/common mesentery/mesenteric adhesion

Drugs & Therapeutics for Gastroschisis

About this section

Drugs for Gastroschisis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Metoclopramideapproved, investigationalPhase 3102364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
KBio2_004686
 
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metonia
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
2
DopamineapprovedPhase 3308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3Neurotransmitter AgentsPhase 314795
4AntiemeticsPhase 33213
5Gastrointestinal AgentsPhase 3, Phase 1, Phase 26401
6Peripheral Nervous System AgentsPhase 318510
7Dopamine D2 Receptor AntagonistsPhase 3258
8Dopamine AgentsPhase 33084
9Dopamine AntagonistsPhase 3927
10Fat Emulsions, IntravenousPhase 229
11Liver ExtractsPhase 23572
12
BilirubinPhase 2103635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
13Hormone AntagonistsPhase 1, Phase 210002
14HormonesPhase 1, Phase 211748
15Glucagon-Like Peptide 1Phase 1, Phase 2620
16glucagonPhase 1, Phase 2379
17Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 29988
18IncretinsPhase 1, Phase 21326
19Omega 3 Fatty AcidNutraceuticalPhase 2912
20Soy BeanNutraceuticalPhase 2455
21Trace Elements3900
22Vitamins3857
23Pharmaceutical Solutions7004
24Micronutrients3901
25lysineNutraceutical77
26BifidobacteriumNutraceutical213

Interventional clinical trials:

(show all 17)
idNameStatusNCT IDPhase
1Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine CareRecruitingNCT01884324Phase 2, Phase 3
2Metoclopramide Pilot TrialRecruitingNCT02098915Phase 3
3Trial of AMNIOECHANGE in Gastroschisis Affected FoetusesActive, not recruitingNCT00127946Phase 3
4Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With GastroschisisCompletedNCT00539292Phase 2
5Compassionate Use of Omegaven in ChildrenRecruitingNCT02370251Phase 2
6Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTerminatedNCT01573286Phase 1, Phase 2
7PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn ChildrenCompletedNCT01296724
8Determination of Lysine Requirement in the Parenterally Fed NeonateCompletedNCT00779753
9Silo Versus Primary Closure for GastroschisisRecruitingNCT01506531
10Sutureless vs Sutured Gastroschisis ClosureRecruitingNCT01094587
11Music Therapy: An Adjunct To Gastroschisis Infants' CareRecruitingNCT01469208
12Probiotics in Infants With GastroschisisRecruitingNCT01316510
13Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis RepairRecruitingNCT02575846
14Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?RecruitingNCT01891279
15Gastroschisis Outcomes of Delivery (GOOD) StudyNot yet recruitingNCT02774746
16Bedside Silo Versus Operative Closure for GastroschisisTerminatedNCT00404690
17Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in InfantsTerminatedNCT01062815

Search NIH Clinical Center for Gastroschisis


Cochrane evidence based reviews: gastroschisis

Genetic Tests for Gastroschisis

About this section

Anatomical Context for Gastroschisis

About this section

MalaCards organs/tissues related to Gastroschisis:

33
Skin, Liver, Breast, Kidney, Heart, Brain, Lung

Animal Models for Gastroschisis or affiliated genes

About this section

MGI Mouse Phenotypes related to Gastroschisis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.0BMP1, ICAM1, IL6, MPO, NPPA
2MP:00053977.6ADD1, BMP1, ICAM1, IL6, MPO, NPPA
3MP:00053856.7BMP1, F5, ICAM1, IL6, MPO, NPPA
4MP:00053766.1ADD1, BMP1, F5, ICAM1, IL6, MPO

Publications for Gastroschisis

About this section

Articles related to Gastroschisis:

(show top 50)    (show all 684)
idTitleAuthorsYear
1
Oligohydramnios and growth restriction do not portend worse prognosis in gastroschisis pregnancies. (26932657)
2016
2
Gastroschisis with Concomitant Jejuno-Ileal Atresia Complicated by Jejunal Perforation. (27123409)
2016
3
Sonographic markers associated with adverse neonatal outcomes among fetuses with gastroschisis: An eleven year, single-center review. (26454131)
2015
4
Isolated prenatal ultrasound findings predict the postnatal course in gastroschisis. (25697276)
2015
5
Feeding Intolerance and Poor Growth in Infants with Gastroschisis: Longitudinal Experience with Consecutive Patients over Thirteen Years. (26500852)
2015
6
Prenatal examination and postmortem findings in fetuses with gastroschisis and omphalocele. (24604302)
2014
7
Anomalies associated with gastroschisis and omphalocele: analysis of 2825 cases from the Texas Birth Defects Registry. (24726103)
2014
8
Prevalence and risk factors for gastroschisis in a public hospital from west MAcxico. (25243388)
2014
9
Gastroschisis, omphalocele or something else? (23531629)
2014
10
Left-sided Gastroschisis: A Rare Congenital Anomaly. (24298510)
2013
11
Gastric contractility in experimental gastroschisis. (23414860)
2013
12
Human milk versus formula after gastroschisis repair: effects on time to full feeds and time to discharge. (23519369)
2013
13
Expectant management compared with elective delivery at 37 weeks for gastroschisis. (23635735)
2013
14
Gastroschisis, destructive brain lesions, and placental infarction in the second trimester suggest a vascular pathogenesis. (23895144)
2013
15
Left-sided gastroschisis with placenta findings: case report and literature review. (22558479)
2012
16
Evolution of critically ill patients with gastroschisis from three tertiary centers. (21437430)
2011
17
Assessing the trend of gastroschisis prevalence in China from 1996 to 2007 using two analytical methods. (21308975)
2011
18
Ultrasound prediction of birthweight and growth restriction in fetal gastroschisis. (20723876)
2010
19
Changes in amniotic fluid index after maternal oral hydration in pregnancies with fetal gastroschisis: initial observations. (20606383)
2010
20
Evisceration and necrosis of gall bladder and evisceration of urinary bladder in a patient of gastroschisis. (20098013)
2010
21
Benchmarking the quality of care of infants with low-risk gastroschisis using a novel risk stratification index. (20236674)
2010
22
Perinatal demography of gastroschisis in North Queensland. (21166913)
2010
23
Gastroschisis associated with an intra-abdominal umbilical vein varix: a report of 2 cases. (19786788)
2009
24
Escape of the yolk sac: a hypothesis to explain the embryogenesis of gastroschisis. (19419415)
2009
25
Spontaneous sutureless closure of the abdominal wall defect in gastroschisis using a commercial wound retractor system. (19705131)
2009
26
Re: M. B. Forrester and R. D. Merz (2006), Comparison of trends in gastroschisis and prenatal illicit drug use rates. J. Toxicol. Environ. Health A 69:1253-1259. (18080905)
2008
27
Rare case of fetal gastroschisis with aplasia of the foot and external genital organs. (18778459)
2008
28
Anaesthetic management of gastroschisis - a review of our practice over the past 5 years. (18613932)
2008
29
Novel intra-operative pulse oximetry monitoring for gastroschisis: a noninvasive monitor of intra-abdominal pressure. (18315652)
2008
30
Fetal abdominal wall repair with a collagen biomatrix in an experimental sheep model for gastroschisis. (18636946)
2008
31
Scheduled preterm delivery for gastroschisis improves postoperative outcome. (18668252)
2008
32
Non-genetic risk factors for gastroschisis. (18655102)
2008
33
Outcomes in neonatal gastroschisis: an institutional experience. (17992713)
2007
34
Ruptured omphalocele with extracorporeal intestines mimicking gastroschisis in a fetus with Turner syndrome. (17694577)
2007
35
Outcomes of pregnancies with fetal gastroschisis. (17766615)
2007
36
Splanchnic perfusion pressure: a better predictor of safe primary closure than intraabdominal pressure in neonatal gastroschisis. (16677879)
2006
37
Does gastroschisis reduction require general anesthesia? A comparative analysis. (16818066)
2006
38
Erythropoietin restores bowel damage and hypoperistalsis in gastroschisis. (16481250)
2006
39
Primary fascial closure in 112 infants with gastroschisis. (16146253)
2005
40
A "plastic" sutureless abdominal wall closure in gastroschisis. (15137009)
2004
41
Fetal home monitoring for the prenatal management of gastroschisis. (15488122)
2004
42
Isolated gastroschisis in successive siblings: a case report and review of the literature. (15193205)
2004
43
Gastroschisis: the effect of labor and ruptured membranes on neonatal outcome. (14710097)
2003
44
An unusual case of gastroschisis with gallbladder evisceration and late postrepair chylous ascites. (9434035)
1997
45
Omphalocele and gastroschisis in Europe: a survey of 3 million births 1980-1990. EUROCAT Working Group. (8533813)
1995
46
Abdominal wall defects: omphalocele and gastroschisis (continuing education credit). (2961975)
1987
47
Omphalocele, hernia of the umbilical cord and gastroschisis. (6232916)
1983
48
Congenital abdominal wall defects: gastroschisis and omphalocele. (6211335)
1982
49
Perinatal aspects of omphalocele and gastroschisis. (930890)
1977
50

Variations for Gastroschisis

About this section

Expression for genes affiliated with Gastroschisis

About this section
Search GEO for disease gene expression data for Gastroschisis.

Pathways for genes affiliated with Gastroschisis

About this section

GO Terms for genes affiliated with Gastroschisis

About this section

Biological processes related to Gastroschisis according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1response to insulinGO:003286810.1IL6, NPPA
2wound healingGO:004206010.1IL6, TGFB3
3cell growthGO:001604910.0IL6, TGFB3
4regulation of MAPK cascadeGO:00434089.9BMP1, TGFB3
5positive regulation of nitric oxide biosynthetic processGO:00454299.8ICAM1, IL6
6response to amino acidGO:00432009.6ICAM1, IL6
7positive regulation of ERK1 and ERK2 cascadeGO:00703749.3ICAM1, IL6
8agingGO:00075689.2IL6, MPO, TGFB3
9cellular protein metabolic processGO:00442679.2ADD1, F5, NPPA

Sources for Gastroschisis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet